Armata Pharmaceuticals, Inc. Liquidation Value
ARMP
Other
Cash & Equivalents
$8.69M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $8.69M
Total Obligations: -$40.04M
$-31.36M
Per share: $-0.86
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $8.69M
AR: $0
Total Obligations: -$40.04M
$-31.36M
Per share: $-0.86
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $8.69M
AR: $0
Inventory: $0
Total Obligations: -$40.04M
$-31.36M
Per share: $-0.86
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-31.36M | $-0.86 |
| Liquid Liquidation Value | $-31.36M | $-0.86 |
| Operating Liquidation Value | $-31.36M | $-0.86 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $8.69M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $8.95M |
| Long-term Debt | N/A |
| Op. Lease Liability | $31.10M |
| Finance Lease | N/A |
| Shares Outstanding | 36.4M |
Explore all 146 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $8.69M | N/A | N/A | $921,000 | $8.95M | N/A | $31.10M | N/A |
| 2025-09-30 | $14.76M | N/A | N/A | $1.28M | $139.95M | N/A | $31.36M | N/A |
| 2025-06-30 | $4.33M | N/A | N/A | $965,000 | $120.08M | N/A | $31.62M | N/A |
| 2025-03-31 | $11.69M | N/A | N/A | $981,000 | $110.54M | N/A | $31.88M | N/A |
▼ Community Notes